Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities

Documenti analoghi

• Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
  di: Pater, Cornel
  Pubblicazione: (2004)
• Drug safety assessment in clinical trials: methodological challenges and opportunities
  di: Singh, Sonal, et al.
  Pubblicazione: (2012)
• Safety assessment of adjuvanted vaccines: Methodological considerations
  di: Da Silva, Fernanda Tavares, et al.
  Pubblicazione: (2015)
• Methodological Considerations in the Design and Implementation of Clinical Trials
  di: Cirrincione, Constance T., et al.
  Pubblicazione: (2013)
• New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery
  di: Tang, Yun, et al.
  Pubblicazione: (2006)